Full-Time
Life Sciences Software Architect
Emerson Electric
10,001+ employees
Global industrial automation software and devices.
No salary listed
Round Rock, TX, USA
Hybrid
Part-time telecommuting permitted.
 Software Engineering (1) |
|---|
- A Bachelor’s degree or the foreign equivalent in Computer Science, Computer Engineering, or a closely related field plus 8 years of progressively responsible experience in a software development occupation.
- The required experience must include the following:
- 5 years of experience in software development on process automation or related products, including the development of DeltaV™ and Syncade™
- 5 years of experience defining and applying modern software architecture, design patterns, and frameworks
- 3 years of experience working in an Agile software development environment, utilizing Scrum and/or Scaled Agile Framework (SAFe) methodologies
- 3 years of experience applying Human-Centered Design (HCD) concepts and strategies in the development of software tools and applications for optimal user experience
- Domestic and international travel required up to 10% of the time.
- Provide high level, long-term technical guidance and leadership to development teams ensuring architectural integrity of the products developed for the Life Sciences industry.
- Analyze customer and technical requirements and produce or validate high quality designs to drive technical direction.
- Architect and design industrial-grade, scalable software applications using proven architectural patterns and technologies to be deployed on premise or cloud platforms.
- Participate in Agile planning and backlog management sessions at the program level and communicate architectural impact for products being planned.
- Work with stakeholders throughout the prioritization of features and translate business objectives into software constructs that span from User Experience to platform resource requirements and operations.
- Provide technical direction across the business covering the CI/CD pipeline, refactoring, and reducing technical debt to ensure long term product viability.
- Collaborate across the business unit to develop technical roadmap for products in all phases of the product life cycle.
- Collaborate with and mentor development teams, helping them to develop and review the right architecture or technical approach to ensure quality and fit for the DeltaV™ platform for Life Sciences.
- Research and provide expertise on latest technologies and complex solutions applicable to future products.
- Contribute to developing standards and best practices in product development using the Agile SAFe framework.
- Communicate technical vision to executive management.
- Part-time telecommuting permitted.
- Travel domestically and internationally up to 10% of the time.
- None
Emerson provides automation technology for critical industries. It supplies software and intelligent devices that monitor, control, and optimize industrial processes in settings like power plants, chemical facilities, and factories. Its products include sensors, controllers, measurement instruments, and software that work together to automate operations, improve safety, and increase efficiency. Unlike many peers, Emerson has narrowed its focus from a broad conglomerate to a dedicated industrial automation company, combining hardware, software, and services and expanding through targeted acquisitions (such as National Instruments) to deliver end-to-end automation solutions. Its goal is to help modern industries run more reliably and efficiently by providing integrated systems that manage complex processes.
Company Size
10,001+
Company Stage
IPO
Headquarters
St. Louis, Missouri
Founded
1890
Simplify's Take
What believers are saying
- AI-enhanced software adoption accelerates across aerospace, semiconductor, transportation via NI LabVIEW+ Suite.
- Underlying orders grew 5% in Q2 2026, led by Software & Systems segment expansion.
- Electrification and energy security trends align with Emerson's automation portfolio through 2028.
What critics are saying
- Rockwell Automation's FactoryTalk AI predictive maintenance captures 15% more hybrid industry orders.
- Schneider Electric undercuts solenoid valves 20% cheaper via Chinese supply chain pricing.
- Weak Europe and China demand reduces measurement instrumentation revenue 10-15% annually.
What makes Emerson Electric unique
- 8.9% market share in US Industrial & Fluid Power Valve Manufacturing with comprehensive sensor portfolio.
- NI test automation platform with Nigel AI reduces development time from days to minutes.
- AspenTech Inmation OT Data Fabric unifies operational technology data across edge, on-premise, cloud.
Help us improve and share your feedback! Did you find this helpful?
Your Connections
People at Emerson Electric who can refer or advise you
Benefits
Health Insurance
Remote Work Options
Flexible Work Hours
Paid Vacation
Parental Leave
Company News
Emerson Electric reported first-quarter results that exceeded earnings expectations, raised its full-year 2026 earnings per share guidance and announced a $250 million share buyback as part of a broader plan to return $10 billion to shareholders by 2028. Despite the positive results, shares fell 5.7%. Management highlighted priorities including electrification, energy security, nearshoring and AI-enhanced software, aiming to align its automation portfolio with long-term infrastructure trends. The company's narrative projects $21.3 billion in revenue and $3.3 billion in earnings by 2028, requiring 6.2% annual revenue growth. However, risks remain around uneven demand in Europe and China, which could offset gains from emerging growth areas. Analysts' fair value estimate of $164.51 suggests a 24% upside from current levels.
Emerson Electric, a Saint Louis-based technology and software company valued at $84.7 billion, has seen its shares rise 25.6% over the past 52 weeks, underperforming the State Street Industrial Select Sector SPDR ETF's 31.7% gain during the same period. The stock trades 8.7% below its 52-week high of $165.15, reached on 11 February. Over the past three months, shares surged 14.7%, slightly trailing the industrial sector ETF's 15.9% gain. Emerson's Q4 2025 results beat expectations, with adjusted earnings per share of $1.46 and revenue of $4.4 billion matching estimates. The company projects full-year earnings between $6.40 and $6.55 per share. Analysts maintain a "moderate buy" consensus rating with a mean price target of $168.25, suggesting 11.6% upside potential.
Emerson Electric has entered into a new $2 billion 364-day credit facility with a syndicate of major banks, replacing its previous $3 billion arrangement. The facility, which currently has no borrowings, maintains unused liquidity support for commercial paper and general corporate purposes. The move comes as Emerson faces near-term challenges, including weaker EBITDA performance and softer guidance that pressured its share price in February. Revenue met expectations, but earnings guidance fell short amid margin pressure in key automation segments and uneven end markets in bulk chemicals, Europe and China. The company is positioning itself as a software and automation leader focused on digital and AI-driven solutions. Analysts' revenue projections for 2028 range from $21.3 billion to $21.7 billion, reflecting differing views on long-term growth prospects.
Emerson Electric has entered into a $2 billion unsecured 364-day credit facility led by JPMorgan Chase, with Bank of America, Citibank and Goldman Sachs participating. The facility supports general corporate purposes, including serving as a liquidity backstop for the company's commercial paper programme, and runs through 9 February 2027. The new agreement replaces Emerson's prior $3 billion 364-day facility dated 11 February 2025, which expired by its terms on 10 February 2026 with no exit fees. There are currently no borrowings outstanding under the new facility, which maintains the company's liquidity and financial flexibility.
Emerson Electric reported first-quarter fiscal 2026 results with underlying orders up 9% year-over-year, marking the fourth consecutive quarter of strong order growth. Underlying sales increased 2%, whilst adjusted earnings per share rose 6% to $1.46. CEO Lal Karsanbhai said growth was driven by demand in power, LNG, semiconductors, life sciences, and aerospace and defence. The company's backlog reached $7.9 billion, up 9% year-over-year, with a book-to-bill ratio of 1.13. Software and Systems orders jumped 23%, whilst Test and Measurement orders climbed 20%. Free cash flow reached $602 million with a 14% margin. Management said a software contract renewal timing issue reduced first-quarter sales growth by approximately one percentage point. The company expects full-year free cash flow growth of about 10%.